Evidence map›Paper›PMID 26966122›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2016

(18)F-DOPA: the versatile radiopharmaceutical.

David Taïeb, Alessio Imperiale, Karel Pacak

Abstract readLetter
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. DecipheringJournal of endocrinological investigation · 2025
    Article
  3. Article
  4. Automation of Copper-MediatedMolecules (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Nucleophilic Synthesis of 6-l-[Molecules (Basel, Switzerland) · 2020
    Review
  9. Synthesis of high-molar-activity [Nature protocols · 2020
    Article
  10. One-pot synthesis of high molar activity 6-[Organic & biomolecular chemistry · 2019
    Article
  11. EarlyEuropean journal of nuclear medicine and molecular imaging · 2019
    Article
  12. European journal of nuclear medicine and molecular imaging · 2017
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David TaïebBiophysics and Nuclear Medecine, La Timone University Hospital, European Center for Research in Medical Imaging, Aix-Marseille University, 264, rue Saint-Pierre 5, Marseille, France. david.taieb@ap-hm.fr.
Alessio ImperialeICube, UMR 7357 University of Strasbourg/CNRS, Strasbourg, France.
Karel PacakSection on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health, Bethesda, MD, 20892, USA.

Funding

Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and ParagangliomaZIAHD008735 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI PACAK, KAREL · 2009 to 2024
$28.4M
Intramural NIH HHS Z99 HD999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RadiopharmaceuticalsBiological TransportDihydroxyphenylalanineHumansNeuroendocrine TumorsNuclear MedicineDihydroxyphenylalaninefluorodopa F 18Radiopharmaceuticals

Identifiers

PMID26966122
PMCPMC7458078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.